Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.005
-0.185 (-8.45%)
Dec 3, 2024, 1:59 PM EST - Market open
Editas Medicine Employees
Editas Medicine had 265 employees as of December 31, 2023. The number of employees increased by 39 or 17.26% compared to the previous year.
Employees
265
Change (1Y)
39
Growth (1Y)
17.26%
Revenue / Employee
$233,053
Profits / Employee
-$794,611
Market Cap
165.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Adaptimmune Therapeutics | 449 |
Enanta Pharmaceuticals | 145 |
BrainsWay | 134 |
Senseonics Holdings | 132 |
Cabaletta Bio | 103 |
MediWound | 100 |
KORU Medical Systems | 82 |
Cassava Sciences | 29 |
EDIT News
- 8 days ago - Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts - Benzinga
- 13 days ago - Editas Medicine, Inc. (EDIT) Presents at Stifel 2024 Healthcare Conference (Transcript) - Seeking Alpha
- 27 days ago - Editas Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Editas Medicine Announces Third Quarter 2024 Results and Business Updates - GlobeNewsWire
- 6 weeks ago - Editas Medicine, Inc. (EDIT) Strategic Update Call Transcript - Seeking Alpha
- 6 weeks ago - Editas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing Therapeutics - GlobeNewsWire
- 6 weeks ago - Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of Concept - GlobeNewsWire
- 2 months ago - Editas Medicine (EDIT) Shares Plunge Amid Biotech Sector Fluctuations - GuruFocus